Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03095885 · ClinicalTrials.gov registry record · NA
A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria
A NA study, sponsored by Allena Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT03095885: Completed NA study, sponsored by Allena Pharmaceuticals.
NCT03095885 is a NA study that has completed, run by Allena Pharmaceuticals. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03095885, a NA study, has completed, sponsored by Allena Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Identify individuals with greater absorption of oxalate based on increase in urinary oxalate excretion in response to a controlled oxalate-rich test meal.
Primary Outcome
Percent of oxalate absorption normalized by baseline was calculated by 100\*\[UOx/test - UOx/baseline\]/Ox intake from the test meal.
Interventions
- OTHER Test Meal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-03 |
| Phase | NA |
What the finished NCT03095885 record still lists
NCT03095885 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Test Meal is the first listed.
NCT03095885 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03095885 about?
NCT03095885 is a clinical study titled "A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria". Identify individuals with greater absorption of oxalate based on increase in urinary oxalate excretion in response to a controlled oxalate-rich test meal.
What is the current status of trial NCT03095885?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2016-11. Estimated completion is 2017-03.
What interventions are being tested in trial NCT03095885?
The interventions under investigation include: Test Meal (OTHER).
Who is sponsoring clinical trial NCT03095885?
This trial is sponsored by Allena Pharmaceuticals, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03095885's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia